Urology · Cleveland, OH
NPI
1821278011
Since 2007
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
11100 Euclid Ave, Department of Surgery
Cleveland, OH, 44106
Phone (216) 844-3027
Groups this clinician bills Medicare through
Medicare paid, 2024
$184K
5,832 services
Medicare patients, 2024
697
Average age 76
Drug cost, 2024
$535K
2,357 prescriptions
Company payments, 2025
$282
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kari A Aretakis was code 81003 (clinical chemistry), 770 times for 467 patients. In total Kari A Aretakis billed 5,832 services in 51 codes, and Medicare paid $184K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-02-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81003 Clinical Chemistry | Office | 770 | 467 | $2.19 | $1,690 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 643 | 423 | $13.03 | $8,381 |
| 99213 Office E&M - Established | Office | 498 | 368 | $68.61 | $34K |
| 99214 Office E&M - Established | Office | 338 | 249 | $99.42 | $34K |
| 51798 Ultrasound - Nonspecific | Office | 157 | 134 | $8.28 | $1,301 |
| 64566 Musculoskeletal | Office | 134 | 22 | $91.76 | $12K |
| 99204 Office E&M - New | Office | 122 | 122 | $123.54 | $15K |
| 52000 Cystourethroscopy | Office | 92 | 91 | $186.37 | $17K |
| 99232 Hospital E&M - Subsequent | Facility | 71 | 53 | $62.99 | $4,472 |
| 76857 Ultrasound - Abdomen and Pelvis | Office | 69 | 68 | $33.85 | $2,336 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 69 | 68 | $81.54 | $5,627 |
| 99231 Hospital E&M - Subsequent | Facility | 66 | 52 | $39.31 | $2,594 |
| 99222 Hospital E&M - Initial | Facility | 54 | 52 | $105.10 | $5,675 |
| 99441 Telephone Services | Office | 38 | 35 | $42.34 | $1,609 |
| 99442 Telephone Services | Office | 37 | 34 | $67.64 | $2,503 |
By year: 2022 $167K for 4,360 services; 2023 $163K for 5,438 services; 2024 $184K for 5,832 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 770 | 467 | $2.19 | $1,690 |
| 36415 Venipuncture Blood Collection | 27 | 25 | $5.88 | $159 |
Medicare prescription drug claims, 2024
In 2024, the drug Kari A Aretakis prescribed most often to Medicare patients was Myrbetriq (Mirabegron), with 271 prescriptions and refills. In total Kari A Aretakis wrote 2,357 Medicare prescriptions that cost $535K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Myrbetriq Mirabegron | 271 | 569 | 94 | $245K |
| Estradiol Generic | 270 | 667 | 124 | $17K |
| Solifenacin Succinate Generic | 230 | 496 | 84 | $9,901 |
| Tamsulosin Hcl Generic | 224 | 595 | 81 | $5,191 |
| Cephalexin Generic | 183 | 332 | 98 | $1,877 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 176 | 192 | 132 | $2,223 |
| Gemtesa Vibegron | 149 | 279 | 42 | $130K |
| Mirabegron Er Mirabegron | 97 | 222 | 39 | $67K |
| Methenamine Hippurate Generic | 80 | 190 | 30 | $8,067 |
| Trospium Chloride Generic | 77 | 164 | 32 | $5,406 |
| Finasteride Generic | 73 | 201 | 21 | $1,645 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 69 | 179 | 23 | $2,096 |
| Doxycycline Hyclate Generic | 50 | 54 | 38 | $416 |
| Trospium Chloride Er Trospium Chloride | 46 | 118 | 18 | $13K |
| Ciprofloxacin Hcl Generic | 46 | 65 | 28 | $199 |
Brand drugs: - claims; generic drugs: 1,867 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kari A Aretakis $282 ($282 in general payments such as food, travel and fees) from 9 companies. The largest payer was Sumitomo Pharma America, Inc. with $49.63.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 2 | $49.63 |
| Medtronic, Inc. MDT | 1 | $44.33 |
| Boston Scientific Corporation BSX | 2 | $36.05 |
| Laborie Medical Technologies Corp. | 2 | $33.15 |
| Avyxa Pharma, LLC | 1 | $29.71 |
| Avation Medical, Inc. | 1 | $27.9 |
| Urogen Pharma, Inc. URGN | 1 | $25.35 |
| Blue Earth Diagnostics | 1 | $19.24 |
| Immunitybio, Inc. IBRX | 1 | $16.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.